Stephen K. Brannan - 09 Jun 2022 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role: Chief Medical Officer
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 09 Jun 2022
Net transactions value: -$508,500
Form type: 4
Filing time: 09 Jun 2022, 16:42:25 UTC
Previous filing: 09 May 2022
Next filing: 11 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Options Exercise	$46,000	+5,000	+33%	$9.20^*	20,000	09 Jun 2022	Direct
transaction	KRTX	Common Stock	Sale	$554,500	-5,000	-25%	$110.90	15,000	09 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-5,000	-9.1%	$0.000000	49,989	09 Jun 2022	Common Stock	5,000	$9.20	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2022.
F2	This option vests as to 12.5% of the shares underlying the option award on each six month anniversary following the vesting commencement date of March 21, 2019.